These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1815055)

  • 41. Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.
    Collins JW; Heyward Hull J; Dumond JB
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):631-640. PubMed ID: 29119381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonlinear pharmacokinetics of 5-fluorouracil in rats.
    Jarugula VR; Lam SS; Boudinot FD
    J Pharm Sci; 1997 Jun; 86(6):756-8. PubMed ID: 9188061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of drug distribution into human milk from physicochemical characteristics.
    Atkinson HC; Begg EJ
    Clin Pharmacokinet; 1990 Feb; 18(2):151-67. PubMed ID: 2318008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats.
    Saadeddin A; Torres-Molina F; Cárcel-Trullols J; Araico A; Peris JE
    AAPS PharmSci; 2004 Jan; 6(1):E1. PubMed ID: 15198502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Graphic method of assessing the maximum cumulative excretion of a drug].
    Firsov AA
    Antibiotiki; 1983 Dec; 28(12):904-8. PubMed ID: 6660844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
    Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
    Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection.
    Tsai TH; Chou CJ; Chen CF
    J Pharm Pharmacol; 1996 Jan; 48(1):57-9. PubMed ID: 8722496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of defibrotide in healthy volunteers.
    Noseda G; Fragiacomo C; Ferrari D
    Haemostasis; 1986; 16 Suppl 1():26-30. PubMed ID: 3754833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humans.
    Drozdzik M; Domanski L; Wojcicki J; Gawronska-Szklarz B; Machoy P; Pudlo A
    J Pharm Pharmacol; 2002 Apr; 54(4):509-14. PubMed ID: 11999128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration.
    Sennello LT; Finley RA; Chu SY; Jagst C; Max D; Rollins DE; Tolman KG
    J Pharm Sci; 1986 Feb; 75(2):158-60. PubMed ID: 3083092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Errors in clearance estimation after bolus injection and arterial sampling: nonexistence of a central compartment.
    Weiss M
    J Pharmacokinet Biopharm; 1997 Apr; 25(2):255-60. PubMed ID: 9408862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.
    Chen YC; Liang W; Hu JL; He GL; Wu XJ; Liu XF; Zhang J; Hu XQ
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):33-43. PubMed ID: 25354895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of moment analysis to nonlinear drug disposition described by the Michaelis-Menten equation.
    Chow AT; Jusko WJ
    Pharm Res; 1987 Feb; 4(1):59-61. PubMed ID: 3508531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A microcomputer program to determine the precision of elimination rate constant and half-life estimates when sampling time is short.
    Guédès JP; Couet W
    Fundam Clin Pharmacol; 1993; 7(2):103-8. PubMed ID: 8486329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.